Nigella sativa supplementation significantly reduces key anthropometric measures such as body fat percentage, body mass index (BMI), waist circumference, and body weight, indicating its potential in obesity management. It also lowers both diastolic and systolic blood pressure, which are crucial factors in cardiovascular risk reduction. On the metabolic front, it improves fasting blood sugar levels, hemoglobin A1c (HbA1c), and postprandial blood glucose, supporting better glycemic control. Furthermore, supplementation favorably modifies lipid profiles by lowering total cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides, and increasing high-density lipoprotein cholesterol (HDL-C).
Summary of Significant Cardiovascular Risk Factor Changes with Nigella sativa Supplementation (Standardized Mean Differences)
| Parameter | SMD (Effect Size) | Evidence Quality |
|---|---|---|
| Body Fat Percentage (BF) | -0.39 | Low |
| Body Mass Index (BMI) | -0.19 | Moderate |
| Waist Circumference (WC) | -0.93 | Very low |
| Weight | -0.25 | Low |
| Diastolic Blood Pressure | -0.40 | Very low |
| Systolic Blood Pressure | -0.47 | Low |
| Fasting Blood Sugar (FBS) | -0.97 | Very low |
| Hemoglobin A1c (HbA1c) | -0.90 | Very low |
| Total Cholesterol (TC) | -0.83 | Very low |
| LDL Cholesterol (LDL-C) | -0.98 | Very low |
| HDL Cholesterol (HDL-C) | +0.45 | Very low |
| Triglycerides (TG) | -0.74 | Very low |
Note: Negative SMD indicates reduction; positive indicates increase (e.g., HDL-C increase)
Encouraging Findings and Population Insights
The benefits are more pronounced at higher dosages (≥2000 mg/day) and longer supplementation durations (≥8 weeks), with older adults, individuals with overweight or obesity, and Middle Eastern populations showing particularly strong responses. These results are consistent across studies of fair to good quality, enhancing the reliability of findings. The improvement in inflammatory markers such as C-reactive protein (CRP) and oxidative stress indicators further support Nigella sativa’s role in reducing cardiovascular disease risk.
Dose-Response and Duration Impact on Cardiovascular Outcomes
| Parameter | Dosage ≥2000 mg/day | Duration ≥8 weeks | Enhanced Effect Observed |
|---|---|---|---|
| Blood Pressure | Yes | Yes | Yes |
| Lipid Profile | Yes | Yes | Yes |
| Glycemic Control | Yes | Yes | Yes |
| Inflammation Markers | Yes | Yes | Yes |
Practical Takeaways for Common People
Incorporating Nigella sativa as a natural supplement may help reduce weight, lower blood pressure, and improve cholesterol and blood sugar levels, thus lowering cardiovascular risk. Nigella sativa is available in various forms, including capsules, oils, and powders, allowing easy integration into daily routines. However, it is advisable to consult healthcare professionals before starting supplementation, especially for those with pre-existing health conditions or who are on medication.
Reference: here
Other Articles:
